Patents by Inventor Soomi Kim

Soomi Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230041723
    Abstract: The present invention relates to a self-sealable injection needle for inhibiting formation of fistula on an eyeball, and a method for manufacturing same. More specifically, the self-sealable injection needle for inhibiting formation of fistula on an eyeball, which is coated with hyaluronic acid on the surface thereof, can immediately close a hole that is inevitably formed when the injection needle is pulled out of an eyeball during the application of an ocular injection to prevent leakage of aqueous humor and to prevent backflow of drug out of the eyeball and can block bacterial penetration to prevent infection in the eyeball.
    Type: Application
    Filed: November 18, 2020
    Publication date: February 9, 2023
    Inventors: Moon Sue LEE, Mi Young KOH, Soomi KIM, Jong Suk SONG, Youngsub EOM
  • Patent number: 7951779
    Abstract: The present invention relates to a method of protecting cells against damage caused at least in part by apoptosis, comprising administering to subjects a therapeutic dose of leumorphin having cytoprotective activity, and a pharmaceutical composition comprising an effective amount of leumorphin having a cytoprotective activity.
    Type: Grant
    Filed: July 6, 2006
    Date of Patent: May 31, 2011
    Assignees: Postech Academy-Industry Foundation, Postech Foundation
    Inventors: Byoung Dae Lee, SooMi Kim, Eun-Mi Hur, Yong-Soo Park, Yun-Hee Kim, Taehoon Lee, Kyong-Tai Kim, Pann-Ghill Suh, Sung Ho Ryu
  • Publication number: 20070010451
    Abstract: The present invention relates to a method of protecting cells against damage caused at least in part by apoptosis, comprising administering to subjects a therapeutic dose of leumorphin having cytoprotective activity, and a pharmaceutical composition comprising an effective amount of leumorphin having a cytoprotective activity.
    Type: Application
    Filed: July 6, 2006
    Publication date: January 11, 2007
    Inventors: Byoung Lee, SooMi Kim, Eun-Mi Hur, Yong-Soo Park, Yun-Hee Kim, Taehoon Lee, Kyong-Tai Kim, Pann-Ghill Suh, Sung Ryu
  • Patent number: 6539416
    Abstract: In a managing system of a mobile agent system, the mobile agent system comprises a plurality of agent systems for generating an agent, executing the agent and performing a movement processing of the agent, at least one agent holding server having an agent holding table, and a network connected thereto, and each of the plurality of agent systems has agent managing section to transfer the agent to the agent holding table of the agent holding server when the mobile agent system does not accept the agent in a case the agent is moved from the agent system under execution to the mobile agent system, and the agent holding server has server managing section to hold the agent in the agent managing table, and to move the agent when the mobile agent system can become accepting it.
    Type: Grant
    Filed: December 17, 1998
    Date of Patent: March 25, 2003
    Assignee: Kabushiki Kaisha Toshiba
    Inventors: Toshiaki Takewaki, Soomi Kim